Hongbo Lu, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 2,970 shares at $76.88 ($228K) on 2026-05-12, disclosed to the SEC on 2026-05-14.
Scheduled sale ($228k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ZBIO | BUY | 2026-02-13 | $585K | — | Filing → |
| ZBIO | BUY | 2025-10-09 | $5.0M | — | Filing → |
| ZBIO | BUY | 2024-09-17 | $1000K | — | Filing → |